The molecular docking assay focuses on specific receptors such as human inducible nitric oxide synthase (iNOS), human pancreatic lipase, human reactive oxygen species (ROS) 1 kinase, and fat mass and obesity-associated (FTO) proteins. This evidence concerns the gene NOS2 and obesity due to melanocortin 4 receptor deficiency.